Keith Martin7 said:And what's a little 700 bucks to escape that damn vaccine, you absolute nutjob! 😁
Actually, it isn't even 700; you were probably thinking of Merck's Lagevrio. This Pfizer one is "nearly 25% lower at roughly $530 per course"
Plus,
The pharmaceutical giant Pfizer announced on Tuesday a deal to make its potential COVID-19 antiviral pill available to the poorest countries in the world.
Pfizer is going to sub-license the production of its promising Paxlovid tablet to generic drug manufacturers to supply 95 low- and middle-income countries, covering about 53 percent of the global population.
Under an agreement made with the Medicines Patent Pool (MPP), Pfizer—which also produces one of the most widespread COVID-19 vaccines alongside the German lab Moderna
—won't be collecting royalties from generic manufacturers, which should drive the cost down. The deal is still subject to regulatory approval.
The Pfizer drug has to be taken alongside the HIV medication ritonavir.
https://www.france24.com/en/americas...r-world-s-poor
So, you think $700 is worth it? If you believe the next step on the menu is being hooked up to a ventilator and facing a 50% chance of death, then sure—go ahead and hand over the cash. Be my guest.
This medication is designed so that you have to take it the second those COVID-19 symptoms pop up—sort of "preventatively"—before you even know how bad the illness is actually going to hit you. So, you get some initial symptoms, test positive on a PCR, and suddenly you're dropping $700 just to swallow five little pills. For the vast majority of people, it wouldn't even be necessary. It’s just a massive cash grab.
It’s high time we started offering lower price points—say, around $100—to developing nations. Honestly, they’d still turn a decent profit at that rate. Just look at the math: if you factor in 7 billion people catching COVID-19 once or even twice a year, those numbers add up fast. It's a win-win.
It’s just like that recent leak over in the UK regarding Pfizer—apparently, it only costs them about 76 cents to manufacture a dose, yet they’re slapping a price tag of $20 to $22 on every single one. Pfizer’s big excuse? They claim they have to recoup all those massive R&D costs and cover the heavy lifting of distribution. Sure, I get it—that makes sense in theory. But here’s the kicker: once you’ve actually accounted for those development costs, why on earth are you still charging $20 or $22 a pop? You should be dropping that price down to maybe $4 or $5 per dose. Heh... give me a break.